skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
Issue Dt:
11/05/2013
Application #:
13380422
Filing Dt:
03/12/2012
Publication #:
Pub Dt:
06/28/2012
PCT #:
US1039829
Inventors:
Irwin M. Chaiken, Umashankara Muddegowda, Karyn McFadden
Title:
ACTIVE CORES OF PEPTIDE TRIAZOLE HIV-1 ENTRY INHIBITORS
Assignment: 1
Reel/Frame:
026368/0800Recorded: 06/01/2011Pages: 5
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
02/25/2011
Exec Dt:
03/01/2011
Exec Dt:
02/25/2011
Assignee:
245 N. 15TH STREET
PHILADELPHIA, PENNSYLVANIA 19102
Correspondent:
DARRYL PRATCHER, RIVERSIDE LAW, LLP
300 FOUR FALLS CORPORATE CENTER, STE 710
300 CONSHOHOCKEN STATE ROAD
PHILADELPHIA, PA 19428
Assignment: 2
Reel/Frame:
034764/0236Recorded: 01/14/2015Pages: 6
Conveyance:
MERGER (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
06/04/2014
Assignee:
3141 CHESTNUT STREET
PHILADELPHIA, PENNSYLVANIA 19104
Correspondent:
KATHRYN DOYLE
SAUL EWING LLP
1500 MARKET STREET, 38TH FLOOR
PHILADELPHIA, PA 19102
Assignment: 3
Reel/Frame:
033776/0593Recorded: 09/18/2014Pages: 2
Conveyance:
CONFIRMATORY LICENSE (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
08/15/2014
Assignee:
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR)
6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980
BETHESDA, MARYLAND 20892-7980
Correspondent:
DIRECTOR, DEITR
NIH, 6705 ROCKLEDGE DRIVE, SUITE 310
MSC 7980
BETHESDA, MD 20892-7980

Search Results as of: 06/20/2024 05:41 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT